Shandong Xinhua Pharmaceutical Co (SZSE:000756) Other Net Income (Loss) : ¥-0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Other Net Income (Loss)?

Shandong Xinhua Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Dec. 2023 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥-0 Mil.

Shandong Xinhua Pharmaceutical Co's quarterly Other Net Income (Loss) increased from Jun. 2023 (¥-0 Mil) to Sep. 2023 (¥-0 Mil) but then stayed the same from Sep. 2023 (¥-0 Mil) to Dec. 2023 (¥-0 Mil).

Shandong Xinhua Pharmaceutical Co's annual Other Net Income (Loss) increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) but then declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil).

Shandong Xinhua Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Other Net Income (Loss) Chart

Shandong Xinhua Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Shandong Xinhua Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Shandong Xinhua Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Shandong Xinhua Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

00719:Hong Kong XIN:Germany

Address

No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086

Website

http://www.xhzy.com

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Headlines

No Headlines